Concentrations en terres rares (REE) et composition isotopique du Nd à l'interface fleuve Amazone/océan Atlantique : traçage de processus et bilan

L'estuaire du fleuve Amazone est le siège d'apports colossaux à l'océan en eau continentale, éléments dissous et particules. Cet estuaire est localisé dans une région cruciale dans la circulation des masses d'eau entre les deux hémisphères. Un échantillonnage du fleuve Amazone et de son estuaire, du plateau continental et du large des côtes brésiliennes et guyanaises a été réalisé dans le cadre du projet de recherche AMANDES (ANR/IRD/INSU). Ce projet est intégré dans la catégorie " étude de processus " au programme international GEOTRACES. Ce doctorat a consisté en l'étude des concentrations en terres rares (REE) et de la composition isotopique (CI) du Nd qui sont des traceurs de source, de transport et de processus. Une méthode inédite et très précise de détermination de concentrations en REE par dilution isotopique a été de ce fait développée. Les données obtenues permettent 1)d'observer que la répartition du Nd entre phases dissoutes, colloïdales et particulaires change radicalement entre l'eau de rivière et l'eau de mer 2) de tracer pour la première fois à l'échelle locale et en milieu naturel des apports conséquents en Nd et REE à la phase dissoute et provenant des particules lithogéniques en suspension et déposées sur la marge continentale 3) de compléter la base de données mondiale de ces traceur mettant en évidence pour les eaux antarctiques intermédiaires une signature géochimique contrastant celle habituellement observée au sud de 30°S et qui pourrait être expliquée par des apports provenant des marges continentales. Ces observations appuient des travaux récents d'expérimentation et de modélisation concluant à la sous-estimation des sédiments marinscomme terme source d'éléments dissous à l'océan, terme crucial pour l'étude les cycles géochimiques globaux.The Amazon estuary is a major source of continental waters, dissolved elements and particles. This estuary is located in a crucial area for inter hemispheric water-mass transfers. A sampling of the Amazon and its estuary, the Brazilian and Guyanese margin and offshore waters was made in the framework of the AMANDES (ANR/IRD/INSU) research project. This Project is intregrated in the "process study" topic of the international research program GEOTRACES. This doctorate consisted in the study of rare earth element concentrations (REE) and Nd isotopic compositions both of these being tracers of source, transport and processes. A precise isototopic dilution method for determining the REE concentrations was thus developed. The obtained data allows to 1) observe a radical change in Nd repartition between dissolved particles and colloids from the river water to the seawater; 2) trace for the first time at a local scale and in a natural environment, consequent lithogenic sources of Nd and REE to the dissolved phase from suspended and margin deposited sediments; complete the world database of these tracers thus revealing a contrasted geoquemical signature for the Antarctic Intermediate Waters with that observed south of 30°S and which could be explained by South Atlantic sourced contributions of margin sediment. Recent experimental and modelling works conclude theunderestimation of marine sediments as a source term for the ocean, a term which is crucial for global geoquemical cycles

Collaborative patch-based super-resolution for diffusion-weighted images

In this paper, a new single image acquisition super-resolution method is proposed to increase image resolution of diffusion weighted (DW) images. Based on a nonlocal patch-based strategy, the proposed method uses a non-diffusion image (b0) to constrain the reconstruction of DW images. An extensive validation is presented with a gold standard built on averaging 10 high-resolution DW acquis itions. A comparison with classical interpo- lation methods such as trilinear and B-spline demonstrates the competitive results of our proposed approach in termsofimprovementsonimagereconstruction,fractiona lanisotropy(FA)estimation,generalizedFAandangular reconstruction for tensor and high angular resolut ion diffusion imaging (HARDI) models. Besides, fi rst results of reconstructed ultra high resolution DW images are presented at 0.6 × 0.6 × 0.6 mm 3 and0.4×0.4×0.4mm 3 using our gold standard based on the average of 10 acquisitions, and on a single acquisition. Finally, fi ber tracking results show the potential of the proposed super-resolution approach to accurately analyze white matter brain architecture.We thank the reviewers for their useful comments that helped improve the paper. We also want to thank the Pr Louis Collins for proofreading this paper and his fruitful comments. Finally, we want to thank Martine Bordessoules for her help during image acquisition of DWI used to build the phantom. This work has been supported by the French grant "HR-DTI" ANR-10-LABX-57 funded by the TRAIL from the French Agence Nationale de la Recherche within the context of the Investments for the Future program. This work has been also partially supported by the French National Agency for Research (Project MultImAD; ANR-09-MNPS-015-01) and by the Spanish grant TIN2011-26727 from the Ministerio de Ciencia e Innovacion. This work benefited from the use of FSL (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/), FiberNavigator (code.google.com/p/fibernavigator/), MRtrix software (http://www. brain.org.au/software/mrtrix/) and ITKsnap (www.itk.org).Coupé, P.; Manjón Herrera, JV.; Chamberland, M.; Descoteaux, M.; Hiba, B. (2013). Collaborative patch-based super-resolution for diffusion-weighted images. NeuroImage. 83:245-261. https://doi.org/10.1016/j.neuroimage.2013.06.030S2452618

The MNI data-sharing and processing ecosystem

AbstractNeuroimaging has been facing a data deluge characterized by the exponential growth of both raw and processed data. As a result, mining the massive quantities of digital data collected in these studies offers unprecedented opportunities and has become paramount for today's research. As the neuroimaging community enters the world of “Big Data”, there has been a concerted push for enhanced sharing initiatives, whether within a multisite study, across studies, or federated and shared publicly. This article will focus on the database and processing ecosystem developed at the Montreal Neurological Institute (MNI) to support multicenter data acquisition both nationally and internationally, create database repositories, facilitate data-sharing initiatives, and leverage existing software toolkits for large-scale data processing

Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission

Abstract Admission procalcitonin measurements and microbiology results were available for 1040 hospitalized adults with coronavirus disease 2019 (from 48 902 included in the International Severe Acute Respiratory and Emerging Infections Consortium World Health Organization Clinical Characterisation Protocol UK study). Although procalcitonin was higher in bacterial coinfection, this was neither clinically significant (median [IQR], 0.33 [0.11–1.70] ng/mL vs 0.24 [0.10–0.90] ng/mL) nor diagnostically useful (area under the receiver operating characteristic curve, 0.56 [95% confidence interval, .51–.60]).</jats:p

Implementation of corticosteroids in treating COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK:prospective observational cohort study

BACKGROUND: Dexamethasone was the first intervention proven to reduce mortality in patients with COVID-19 being treated in hospital. We aimed to evaluate the adoption of corticosteroids in the treatment of COVID-19 in the UK after the RECOVERY trial publication on June 16, 2020, and to identify discrepancies in care. METHODS: We did an audit of clinical implementation of corticosteroids in a prospective, observational, cohort study in 237 UK acute care hospitals between March 16, 2020, and April 14, 2021, restricted to patients aged 18 years or older with proven or high likelihood of COVID-19, who received supplementary oxygen. The primary outcome was administration of dexamethasone, prednisolone, hydrocortisone, or methylprednisolone. This study is registered with ISRCTN, ISRCTN66726260. FINDINGS: Between June 17, 2020, and April 14, 2021, 47 795 (75·2%) of 63 525 of patients on supplementary oxygen received corticosteroids, higher among patients requiring critical care than in those who received ward care (11 185 [86·6%] of 12 909 vs 36 415 [72·4%] of 50 278). Patients 50 years or older were significantly less likely to receive corticosteroids than those younger than 50 years (adjusted odds ratio 0·79 [95% CI 0·70–0·89], p=0·0001, for 70–79 years; 0·52 [0·46–0·58], p80 years), independent of patient demographics and illness severity. 84 (54·2%) of 155 pregnant women received corticosteroids. Rates of corticosteroid administration increased from 27·5% in the week before June 16, 2020, to 75–80% in January, 2021. INTERPRETATION: Implementation of corticosteroids into clinical practice in the UK for patients with COVID-19 has been successful, but not universal. Patients older than 70 years, independent of illness severity, chronic neurological disease, and dementia, were less likely to receive corticosteroids than those who were younger, as were pregnant women. This could reflect appropriate clinical decision making, but the possibility of inequitable access to life-saving care should be considered. FUNDING: UK National Institute for Health Research and UK Medical Research Council

Search for dark matter produced in association with bottom or top quarks in √s = 13 TeV pp collisions with the ATLAS detector

A search for weakly interacting massive particle dark matter produced in association with bottom or top quarks is presented. Final states containing third-generation quarks and miss- ing transverse momentum are considered. The analysis uses 36.1 fb−1 of proton–proton collision data recorded by the ATLAS experiment at √s = 13 TeV in 2015 and 2016. No significant excess of events above the estimated backgrounds is observed. The results are in- terpreted in the framework of simplified models of spin-0 dark-matter mediators. For colour- neutral spin-0 mediators produced in association with top quarks and decaying into a pair of dark-matter particles, mediator masses below 50 GeV are excluded assuming a dark-matter candidate mass of 1 GeV and unitary couplings. For scalar and pseudoscalar mediators produced in association with bottom quarks, the search sets limits on the production cross- section of 300 times the predicted rate for mediators with masses between 10 and 50 GeV and assuming a dark-matter mass of 1 GeV and unitary coupling. Constraints on colour- charged scalar simplified models are also presented. Assuming a dark-matter particle mass of 35 GeV, mediator particles with mass below 1.1 TeV are excluded for couplings yielding a dark-matter relic density consistent with measurements

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

Background: Microbiological characterisation of co-infections and secondary infections in patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe microbiologically confirmed co-infections and secondary infections, and antimicrobial use, in patients admitted to hospital with COVID-19. Methods: The International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) WHO Clinical Characterisation Protocol UK (CCP-UK) study is an ongoing, prospective cohort study recruiting inpatients from 260 hospitals in England, Scotland, and Wales, conducted by the ISARIC Coronavirus Clinical Characterisation Consortium. Patients with a confirmed or clinician-defined high likelihood of SARS-CoV-2 infection were eligible for inclusion in the ISARIC WHO CCP-UK study. For this specific study, we excluded patients with a recorded negative SARS-CoV-2 test result and those without a recorded outcome at 28 days after admission. Demographic, clinical, laboratory, therapeutic, and outcome data were collected using a prespecified case report form. Organisms considered clinically insignificant were excluded. Findings: We analysed data from 48 902 patients admitted to hospital between Feb 6 and June 8, 2020. The median patient age was 74 years (IQR 59–84) and 20 786 (42·6%) of 48 765 patients were female. Microbiological investigations were recorded for 8649 (17·7%) of 48 902 patients, with clinically significant COVID-19-related respiratory or bloodstream culture results recorded for 1107 patients. 762 (70·6%) of 1080 infections were secondary, occurring more than 2 days after hospital admission. Staphylococcus aureus and Haemophilus influenzae were the most common pathogens causing respiratory co-infections (diagnosed ≤2 days after admission), with Enterobacteriaceae and S aureus most common in secondary respiratory infections. Bloodstream infections were most frequently caused by Escherichia coli and S aureus. Among patients with available data, 13 390 (37·0%) of 36 145 had received antimicrobials in the community for this illness episode before hospital admission and 39 258 (85·2%) of 46 061 patients with inpatient antimicrobial data received one or more antimicrobials at some point during their admission (highest for patients in critical care). We identified frequent use of broad-spectrum agents and use of carbapenems rather than carbapenem-sparing alternatives. Interpretation: In patients admitted to hospital with COVID-19, microbiologically confirmed bacterial infections are rare, and more likely to be secondary infections. Gram-negative organisms and S aureus are the predominant pathogens. The frequency and nature of antimicrobial use are concerning, but tractable targets for stewardship interventions exist. Funding: National Institute for Health Research (NIHR), UK Medical Research Council, Wellcome Trust, UK Department for International Development, Bill &amp; Melinda Gates Foundation, EU Platform for European Preparedness Against (Re-)emerging Epidemics, NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool, and NIHR HPRU in Respiratory Infections at Imperial College London